Rule 144 filing details 87-share LH (NYSE: LH) stock sale
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
A holder of Laboratory Corporation of America Holdings (LH) common stock has filed a Rule 144 notice to sell 87 shares through Fidelity Brokerage Services on the NYSE, with an approximate sale date of 02/12/2026 and an aggregate market value of $25,266.54.
The 87 shares were acquired on 02/11/2026 via restricted stock vesting from the issuer as compensation. In the past three months, Jonathan Meltzer sold LH common stock in two transactions: 88 shares on 02/09/2026 for $24,246.64 and 91 shares on 02/10/2026 for $25,187.89.
Positive
- None.
Negative
- None.
FAQ
What does the latest Rule 144 notice for LH disclose?
The notice discloses a planned sale of 87 shares of LH common stock on or about 02/12/2026. The shares are to be sold on the NYSE through Fidelity Brokerage Services for an aggregate market value of $25,266.54.
What recent LH stock sales are reported for Jonathan Meltzer?
The filing reports two recent LH common stock sales by Jonathan Meltzer. He sold 88 shares on 02/09/2026 for gross proceeds of $24,246.64 and 91 shares on 02/10/2026 for gross proceeds of $25,187.89, both listed as separate transactions.
What class of LH securities is covered by this Rule 144 filing?
The filing covers LH common stock as the class of securities to be sold. It specifies that 87 common shares are intended for sale, with an aggregate market value of $25,266.54, and identifies the NYSE as the securities exchange.